시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 백선 치료 시장 보고서(2025년)
Ringworm Treatment Global Market Report 2025
상품코드 : 1720886
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,265,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,056,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,846,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

백선 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 자연스럽게 항진균제나 허브 항진균제에 대한 소비자의 기호의 고조등이 있습니다. 주요 동향으로서는 나노 테크놀로지에 근거한 항진균 치료의 개발, 진균 감염 진단에 있어서의 인공지능의 이용 확대, 처방전에 근거한 항진균 치료에 대한 수요 증가, 소비자 직접 판매의 항진균 브랜드의 확장이 있습니다.

곰팡이 감염증의 유병률 증가는 백선 치료 시장의 성장을 견인할 것으로 예측됩니다. 이러한 감염의 증가는 면역 억제 치료제 사용 증가, 지구 온난화, 면역 체계가 손상된 인구 증가 등의 요인에 기인합니다. 백선 치료는 진균 감염증의 관리에 있어서, 특히 감염되기 쉬운 사람들의 감염 확대를 막아, 합병증을 줄이고, 감염률을 컨트롤 하는 효과적인 항진균 치료를 제공하는 것으로, 중요한 역할을 완수하고 있습니다. 예를 들면, 2024년 11월, 영국의 정부 Health Security Agency(UKHSA)는 2022년 영국의 이스트균에 의한 혈류 감염증이 전년 대비 4% 증가한 것을 보고하고, 진균 관련 건강 문제 증가 경향을 부각시켰습니다. 세계에서 연간 650만건의 비율로 발생해, 약 380만명이 사망, 그중 250만명이 이러한 감염증에 직접 기인한다고 추정하고 있습니다. 매년 210만명 이상이 침습성 아스페르길루스증에 걸립니다. 그 결과, 진균 감염증의 발생률 증가에 따라 백선 치료 시장이 확대되고 있습니다.

또한 의료시설의 고도화도 백선 치료 시장의 성장에 기여하고 있습니다. 인프라의 개선, 환자 중심의 케어에의 주력, 인구 증가, 고령화에 의해 이러한 시설의 강화가 진행되고 있습니다. 보다 효과적인 치료법의 도입을 촉진하는 등, 건강 관리의 향상이 지원되고 있습니다. 2023년 5월 미국의 비영리 단체인 미국 의료 협회는 미국 병원 수가 전년도 6,093개에서 6,129개로 증가했다고 보고했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Ringworm treatment involves the use of medications to eliminate the fungal infection caused by dermatophytes, relieve symptoms such as itching and redness, and prevent the spread of the contagious condition to other body areas or individuals. Along with medication, maintaining proper hygiene, keeping affected areas dry, and avoiding direct contact with infected individuals or surfaces help manage and prevent the recurrence of ringworm infections.

The primary drug classes for ringworm treatment include antifungals and combination drugs. Antifungals are designed to prevent, control, or eliminate fungal infections by targeting fungal cells while minimizing harm to the host. Treatment options address various types of ringworm, such as tinea corporis, tinea pedis, tinea cruris, tinea capitis, and tinea manuum, with administration routes including topical, oral, and parenteral. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The ringworm treatment market research report is one of a series of new reports from The Business Research Company that provides ringworm treatment market statistics, including ringworm treatment industry global market size, regional shares, competitors with a ringworm treatment market share, detailed ringworm treatment market segments, market trends and opportunities, and any further data you may need to thrive in the ringworm treatment industry. This ringworm treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ringworm treatment market size has grown strongly in recent years. It will grow from $11.50 billion in 2024 to $12.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to the increasing prevalence of fungal infections, greater awareness of hygiene and personal care, the growing availability of over-the-counter antifungal medications, the rising adoption of topical antifungal treatments, and the increasing incidence of immunocompromised conditions.

The ringworm treatment market size is expected to see strong growth in the next few years. It will grow to $15.14 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to the increasing demand for combination therapies, the rising prevalence of diabetes and other immunosuppressive conditions, the expansion of telemedicine for dermatological treatments, growing research on novel antifungal compounds, and the rising consumer preference for natural and herbal antifungal products. Major trends include the development of nanotechnology-based antifungal treatments, the increasing use of artificial intelligence in fungal infection diagnosis, the rising demand for prescription-based antifungal therapies, the expansion of direct-to-consumer antifungal brands, and the growing integration of antifungal treatments in skincare products.

The increasing prevalence of fungal infections is expected to drive the growth of the ringworm treatment market. Fungal infections occur when fungi overgrow or invade the body, affecting various organs and tissues. The rise in these infections is attributed to factors such as increased use of immunosuppressive treatments, global warming, and a growing population with compromised immune systems. Ringworm treatment plays a crucial role in managing fungal infections by providing effective antifungal therapies that prevent spread, reduce complications, and control infection rates, particularly in vulnerable populations. For instance, in November 2024, the UK Health Security Agency (UKHSA), a UK-based government agency, reported a 4% rise in bloodstream infections caused by yeast in England in 2022 compared to the previous year, highlighting an upward trend in fungal-related health issues. Additionally, in September 2024, the International Society for Infectious Diseases, a US-based nonprofit organization, estimated that invasive fungal infections occur at an annual rate of 6.5 million cases globally, leading to approximately 3.8 million deaths, with 2.5 million directly attributed to these infections. Over 2.1 million people develop invasive aspergillosis each year. As a result, the increasing incidence of fungal infections is fueling the expansion of the ringworm treatment market.

The advancement of healthcare facilities is also expected to contribute to the growth of the ringworm treatment market. Healthcare facilities, including hospitals, clinics, and diagnostic centers, provide essential medical services for diagnosing and treating various conditions. Improvements in healthcare infrastructure, a focus on patient-centered care, population growth, and an aging demographic have driven enhancements in these facilities. The availability of ringworm treatment has supported healthcare improvements by fostering specialized dermatological care, increasing patient education on fungal infections, and promoting the adoption of accessible, effective treatment options. These efforts help healthcare systems expand their ability to manage skin-related diseases more efficiently, leading to improved public health outcomes. For example, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported that the number of hospitals in the United States increased from 6,093 in the previous year to 6,129, reflecting a 0.591% growth. This improvement in healthcare infrastructure is further driving the expansion of the ringworm treatment market.

Companies in the ringworm treatment market are focusing on developing innovative solutions, such as full-cycle skin infection control formulations, to enhance treatment effectiveness and prevent recurrence. A full-cycle skin infection control formulation is designed to target all stages of a skin infection, from eliminating the pathogen to preventing recurrence, soothing inflammation, and promoting skin healing. For instance, in May 2022, Bayer AG, a Germany-based pharmaceutical company, launched an improved version of Canesten, an antifungal brand. The updated Canesten product line features an advanced formulation designed to provide faster relief from fungal infections while being gentle on the skin. The relaunch emphasizes a full-cycle treatment approach by combining antifungal, anti-inflammatory, and skin-soothing properties in a single product, ensuring not only effective infection control but also long-term prevention of recurrence. These innovations are shaping the future of the ringworm treatment market by providing more comprehensive and patient-friendly solutions.

Major players in the ringworm treatment market are Pfizer Inc., Merck & Co. Inc., Bayer Healthcare, Sanofi-Aventis, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc (GSK), Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr Reddy's Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Zydus Group, Glenmark Pharmaceuticals Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Enzon Pharmaceuticals.

North America was the largest region in the ringworm treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ringworm treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ringworm treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ringworm treatment market consists of sales of adjunctive treatment, azoles, and allylamines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ringworm Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ringworm treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for ringworm treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ringworm treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Ringworm Treatment Market Characteristics

3. Ringworm Treatment Market Trends And Strategies

4. Ringworm Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Ringworm Treatment Growth Analysis And Strategic Analysis Framework

6. Ringworm Treatment Market Segmentation

7. Ringworm Treatment Market Regional And Country Analysis

8. Asia-Pacific Ringworm Treatment Market

9. China Ringworm Treatment Market

10. India Ringworm Treatment Market

11. Japan Ringworm Treatment Market

12. Australia Ringworm Treatment Market

13. Indonesia Ringworm Treatment Market

14. South Korea Ringworm Treatment Market

15. Western Europe Ringworm Treatment Market

16. UK Ringworm Treatment Market

17. Germany Ringworm Treatment Market

18. France Ringworm Treatment Market

19. Italy Ringworm Treatment Market

20. Spain Ringworm Treatment Market

21. Eastern Europe Ringworm Treatment Market

22. Russia Ringworm Treatment Market

23. North America Ringworm Treatment Market

24. USA Ringworm Treatment Market

25. Canada Ringworm Treatment Market

26. South America Ringworm Treatment Market

27. Brazil Ringworm Treatment Market

28. Middle East Ringworm Treatment Market

29. Africa Ringworm Treatment Market

30. Ringworm Treatment Market Competitive Landscape And Company Profiles

31. Ringworm Treatment Market Other Major And Innovative Companies

32. Global Ringworm Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ringworm Treatment Market

34. Recent Developments In The Ringworm Treatment Market

35. Ringworm Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기